YATHARTH
1 call
Concalls & earnings callsYatharth Hospital & Trauma Care Services Limited
Every summarised call, newest first. Latest is Q1 FY27, held 11 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Yatharth delivered its highest ever quarterly revenue and profits, with 51% revenue growth driven by successful integration and rapid scaling of newer hospitals, while maintaining a focus on premium payer mix and expansion to 5,000 beds.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹392.7 Cr | 51% year-over-year | |
| EBITDA | ₹91.7 Cr | 39% year-over-year | |
| Consolidated EBITDA Margin | 23.3% | — | |
| Adjusted EBITDA Margin (ex-New Delhi & Faridabad S20) | 28.1% | — |
Latest guidance
- FY27 revenue growth will surpass last year's 37% YoY growth.
- FY27 EBITDA margin targeted upwards of 24%.
- ARPOB growth expected at 9-10% YoY.
- Target to reach 5,000 beds in less than three years.
- Gurugram 250-bed facility expected to commence operations by Q1 FY28.
- Expect to add at least one new hospital asset in FY27.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹219.16 Cr+31.4% YoY+0.6% QoQ | ₹30.49 Cr+3.4% YoY-1.5% QoQ | ₹3.57-6.8% YoY-0.6% QoQ |
| Q2 FY25 | ₹217.77 Cr+27.1% YoY+2.8% QoQ | ₹30.95 Cr+12.1% YoY+1.9% QoQ | ₹3.59-5.5% YoY+1.4% QoQ |
| Q1 FY25 | ₹211.78 Cr+37.1% YoY+19.1% QoQ | ₹30.38 Cr+59.6% YoY-20.8% QoQ | ₹3.54+21.6% YoY-27% QoQ |
| Q4 FY24 | ₹177.75 Cr— YoY+6.6% QoQ | ₹38.35 Cr— YoY+30% QoQ | ₹4.85— YoY+26.6% QoQ |
| Q3 FY24 | ₹166.79 Cr— YoY-2.6% QoQ | ₹29.49 Cr— YoY+6.8% QoQ | ₹3.83— YoY+0.8% QoQ |
Call history
- Q1 FY27Positive tone
Yatharth delivered its highest ever quarterly revenue and profits, with 51% revenue growth driven by successful integration and rapid scaling of newer hospitals, while maintaining a focus on premium payer mix and expansion to 5,000 beds.
- Revenue
- ₹392.7 Cr51% year-over-year
- EBITDA
- ₹91.7 Cr39% year-over-year